-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Jy9JifPaRzsBXgTQKTKJXvDp+E/9/CZNiNYETokw6+6Q++Jt0xuVa7WRyTIxvIj9
 wKouKOxso2yxITN4Mr6f/g==

<SEC-DOCUMENT>0001019687-07-001070.txt : 20070413
<SEC-HEADER>0001019687-07-001070.hdr.sgml : 20070413
<ACCEPTANCE-DATETIME>20070412204510
ACCESSION NUMBER:		0001019687-07-001070
CONFORMED SUBMISSION TYPE:	AW
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20070413
DATE AS OF CHANGE:		20070412

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AETHLON MEDICAL INC
		CENTRAL INDEX KEY:			0000882291
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				133632859
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		AW
		SEC ACT:		
		SEC FILE NUMBER:	333-141893
		FILM NUMBER:		07764558

	BUSINESS ADDRESS:	
		STREET 1:		7825 FAY AVENUE SUITE 200
		CITY:			LAJOLLA
		STATE:			CA
		ZIP:			92037
		BUSINESS PHONE:		2129120930

	MAIL ADDRESS:	
		STREET 1:		7825 FAY AVENUE SUITE 200
		CITY:			LAJOLLA
		STATE:			CA
		ZIP:			92037

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BISHOP EQUITIES INC
		DATE OF NAME CHANGE:	19930602
</SEC-HEADER>
<DOCUMENT>
<TYPE>AW
<SEQUENCE>1
<FILENAME>aethlon_aw-041207.txt
<TEXT>
<PAGE>

                              AETHLON MEDICAL, INC.
                       3030 BUNKER HILL STREET, SUITE 4000
                           SAN DIEGO, CALIFORNIA 92109
                                 (858) 459-7800

April 12, 2007

VIA EDGAR
- ---------

Securities and Exchange Commission
100 F St., NE
Washington, DC 20549

        Aethlon Medical, Inc.
        Amendment to Registration Statement on Form SB-2 filed on APRIL 11, 2007
        File No. 333-141893 (the "REGISTRATION STATEMENT")

Ladies and Gentlemen:

         Pursuant to Rule 477 of the Securities Act of 1933, as amended, we
hereby withdraw the above referenced Registration Statement Amendment (the
"Registration Statement Amendment") of Aethlon Medical, Inc., a Nevada company,
and hereby request that an order consenting to the withdrawal be entered by the
Securities and Exchange Commission. The Registration Statement Amendment was
inadvertently filed, through no fault of the Company or its counsel, on EDGAR as
submission type "SB-2/A" as opposed to EDGAR submission type "SB-2". Therefore
we request withdrawal of such Registration Statement Amendment, together with
all exhibits thereto. Following the filing of this letter, the Registration
Statement Amendment will be filed on EDGAR submission type "SB-2" as an initial
filing. Aethlon Medical, Inc. further advises the Commission that no securities
included in the Registration Statement Amendment have been sold or otherwise
distributed.

         Please note that the initial Registration Statement on Form SB-2 filed
on APRIL 4, 2007, file No. 333-141893 should remain on file and therefore is NOT
requested to be withdrawn.

         Your assistance in this matter is greatly appreciated. If you have any
questions regarding this request, please contact Peter Hogan, Esq. at
310-208-1182. Thank you.

                                            Sincerely,

                                            AETHLON MEDICAL, INC.

                                            By:  /s/ James A. Joyce
                                                 ------------------------------
                                                 James A. Joyce, CEO

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
